Stereotactic Radiosurgery Registry
The American Association of Neurological Surgeons (AANS) and the American Society for Radiation Oncology (ASTRO), with the support of Brainlab and Elekta, have developed a national prospective registry for stereotactic radiosurgery (SRS) treatments. Stereotactic radiosurgery is a minimally invasive approach using imaging guidance and stereotactic principles to deliver radiation to targeted cells within the body. It has become an important part of the treatment of brain metastases, benign brain tumors, and arteriovenous malformations (AVMs).
The registry objectives are to:
- Define national patterns of care in radiosurgery
- Improve healthcare outcomes and support informed decision-making
- Explore the potential to lower the cost of care delivery to patients
Key registry elements include:
- The participation of 30 high-volume sites across the nation for an initial three-year phase
- The collection of patient reported outcomes at routine intervals (3 to 6 months after SRS)
The registry is aimed at providing national benchmarks for SRS treatments in order to provide clinicians and patients the data required to make informed treatment decisions. Over time, the potential for significant scientific studies, based on data collected through the registry, will begin to make an impact on the care of neurosurgical patients. Registry information will be used to help pinpoint more effective treatments for conditions affecting certain patient populations.